|Articles|November 10, 2022
- Applied Clinical Trials-11-01-2022
- Volume 31
- Issue 11
Applied Clinical Trials November 2022 Issue (PDF)
Advertisement
Articles in this issue
almost 4 years ago
Mobilizing and Maintaining Clinical Trials in Midst of Waralmost 4 years ago
The Implications of Inflation for Drug Developmentalmost 4 years ago
Implementing Numeric Rating and Visual Analog Scales in an eCOA Solutionalmost 4 years ago
‘Dogma’ About Innovation vs. Access Impeding EU Fixes for Rare Diseasesalmost 4 years ago
When Does Patient Centricity Equal Burden?almost 4 years ago
The State of Data FAIRification in Clinical Researchalmost 4 years ago
“Culture of Quality” In Actionalmost 4 years ago
FDA Expands Oversight of Cell and Gene Therapiesalmost 4 years ago
Anticipating Careless Responders in Survey Design and Analysisabout 4 years ago
Towards a Global Implementation of eConsent in Clinical TrialsAdvertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Real-Time Trials Need More Than AI: Why Operational Trial Infrastructure Matters
2
ACT Brief: Commercial Strategy Shaping Early Clinical Development, Real-Time Trials Require Operational Infrastructure, and AI Site Engagement Gap
3
FDA Makes Case for Overhauling Early Clinical Development to Reclaim US Leadership
4
ACT Brief: Funding Gaps and Indication Decisions in Early-Stage Programs, Recruitment Funnel Leak Diagnosis, and Mega-Merger Speculation Denial
5